Body Fat Accretion Research Articles

Gender-specific effects on food intake but no inhibition of age-related fat accretion in transgenic mice overexpressing human IGFBP-2 lacking the Cardin-Weintraub sequence motif.

IGFBP-2 affects growth and metabolism and is thought to impact on energy homeostasis and the accretion of body fat via its heparin binding domains (HBD). In order to assess the function of the HBD present in the linker domain (HBD1) we have generated transgenic mice overexpressing mutant human IGFBP-2 lacking the PKKLRP sequence and carrying a PNNLAP sequence instead. Transgenic mice expressed high amounts of human IGFBP-2, while endogenous IGFBP-2 or IGF-I serum concentrations were not affected. In both genders we performed a longitudinal analysis of growth and metabolism including at least 4 separate time points between the age of 10 and 52weeks. Body composition was assessed by nuclear magnetic resonance (NMR) analysis. Food intake was recorded by an automated online-monitoring. We describe negative effects of mutant human IGFBP-2 on body weight, longitudinal growth and lean body mass (p < 0.05). Very clearly, negative effects of mutant IGFBP-2 were not observed for fat mass accretion throughout life. Instead, relative fat mass was increased in transgenic mice of both genders (p < 0.05). In male mice transgene expression significantly increased absolute mass of total body fat over all age groups (p < 0.05). Food intake was increased in female but decreased in male transgenic mice at an age of 11weeks. Thus our study clearly provides gender- and time-specific effects of HBD1-deficient hIGFBP-2 (H1d-BP-2) on fat mass accretion and food intake. While our data are in principal agreement with current knowledge on the role of HB-domains for fat accretion we now may also speculate on a role of HBD1 for the control of eating behavior.

Dietary supplements to a low protein diet may affect the occurrence of hepatic lipidosis in mink - a strict carnivore

Hepatic lipidosis is a multifactorial disease and may be caused by a number of factors such as low protein provision, feed deprivation, rapid accretion or mobilisation of body fat all resulting in metabolic imbalances.

Aging and energetics' 'Top 40' future research opportunities 2010-2013.

As part of a coordinated effort to expand our research activity at the interface of Aging and Energetics a team of investigators at The University of Alabama at Birmingham systematically assayed and catalogued the top research priorities identified in leading publications in that domain, believing the result would be useful to the scientific community at large. To identify research priorities and opportunities in the domain of aging and energetics as advocated in the 40 most cited papers related to aging and energetics in the last 4 years. The investigators conducted a search for papers on aging and energetics in Scopus, ranked the resulting papers by number of times they were cited, and selected the ten most-cited papers in each of the four years that include 2010 to 2013, inclusive. Ten research categories were identified from the 40 papers. These included: (1) Calorie restriction (CR) longevity response, (2) role of mTOR (mechanistic target of Rapamycin) and related factors in lifespan extension, (3) nutrient effects beyond energy (especially resveratrol, omega-3 fatty acids, and selected amino acids), 4) autophagy and increased longevity and health, (5) aging-associated predictors of chronic disease, (6) use and effects of mesenchymal stem cells (MSCs), (7) telomeres relative to aging and energetics, (8) accretion and effects of body fat, (9) the aging heart, and (10) mitochondria, reactive oxygen species, and cellular energetics. The field is rich with exciting opportunities to build upon our existing knowledge about the relations among aspects of aging and aspects of energetics and to better understand the mechanisms which connect them.

Pathophysiological characterization of metabolic syndrome in overweight, obese and type 2 diabetic Algerian subjects: interest of adipokines as dysmetabolic biomarkers

The body fat accretion (BFA) is correlated to energy homeostasis and/or hemodynamic dysfunction, being mediated by insulin resistance, dyslipidemia and recently by adipokines. In this study, we investigated the associations between metabolic syndrome markers and the secretion disturbs of leptin, adiponectin and resistin during overweight (OW), obesity (OB) and type 2 diabetes de type 2 (T2DM) stages. The study was undertaken on 240 subjects who were divided in 3 groups: overweight, obese and diabetic groups, according to age, sex and the BMI value. The metabolic syndrome was investigated according to the NCEP/ATPIII criteria. Insulin resistance was assessed by HOMA model. Metabolic parameters were determined on Cobas®. Adipokines (leptin, adiponectin, resistin) by enzyme linked immunosorbent assay on human ELISA reader - Biotek ELX 800. The adipokines secretion is influenced by the adipose tissue accretion and insulin resistance state. The BFA in OB and OW subjects is positively correlated to the increase of serum leptin, whereas the serum adiponectin is reduced. The serum adipokines profile is modulated differently between men and women, particularly for leptin. Resistin secretion follows the evolution of leptinemia. It appears that adipokines as major dysmetabolic biomarkers, and can be considered as relevant biological tools in the diagnosis of cardiovascular and T2DM predictive risk in overweight and obese subjects.

Intestinal Alkaline Phosphatase Functions as a Longevity Factor

A hallmark of aging is the deterioration of cellular functions, including the immune and inflammatory responses. ‘Inflammaging’ is a chronic low-grade inflammatory state that increases with age and thus is a companion manifestation of aging. It is thought that body fat accretion, increased intestinal permeability, persistent endotoxemia, cellular immunity decay, and ectopic activation of oxidative stress are responsible for inflammaging. The brush border enzyme Intestinal alkaline phosphatase (IAP) detoxifies many bacterial inflammatory factors, including lipopolysaccharides (LPS), reduces gut permeability to endotoxins, and prevents systemic inflammation.

Long-chain SFA at thesn-1, 3 positions of TAG reduce body fat deposition in C57BL/6 mice

The present study aimed to determine the effect of positional distribution of long-chain SFA in TAG, especially at the sn-1, 3 positions, on fat deposition using the C57BL/6 mouse model. Throughout the 15 weeks of the study, mice were fed with diets fortified with palm olein (POo), chemically interesterified POo (IPOo) and soyabean oil (SOY). Mice receiving the SOY-enriched diet gained significantly higher amounts of subcutaneous fat (P=0·011) and total fat (P=0·013) compared with the POo group, despite similar body mass gain being recorded. During normalisation with food consumption to obtain the fat:feed ratio, mice fed with the POo-enriched diet exhibited significantly lower visceral (P=0·044), subcutaneous (P=0·006) and total (P=0·003) fat:feed than those fed with the SOY-enriched diet. It is noteworthy that mice fed with the IPOo-enriched diet gained 14·3% more fat per food consumed when compared with the POo group (P=0·013), despite their identical total fatty acid compositions. This was mainly attributed to the higher content of long-chain SFA at the sn-1, 3 positions of TAG in POo, which results in delayed absorption after deacylation as evidenced by the higher amounts of long-chain SFA excreted in the faeces of mice fed with the POo-enriched diet. Negative correlations were found between the subcutaneous, visceral as well as total fat accretion per food consumption and the total SFA content at the sn-1, 3 positions, while no relationships were found for MUFA and PUFA. The present results show that the positional distribution of long-chain SFA exerts a more profound effect on body fat accretion than the total SFA content.

Conjugated Linoleic Acid as an Immunity Enhancer: A Review

Conjugated linoleic acid (CLA, 18:2) is a mixture of positional and geometric isomers of linoleic acid with two conjugated double bonds at various carbon positions in the fatty acid, found in nature, and do not have any known negative side effects. The most abundant source of natural CLA is the meat and dairy products of grass-fed ruminants such as cows, sheep and goats. CLA is synthesized endogenously by two pathways. The beneficial effects of CLA is reducing body fat accretion and increasing the percentage of body protein, delaying the onset of type II diabetes, retarding the development of atherosclerosis, improving the mineralization of bone, anticarcinogenic. CLA may be a more potent antioxidant than αtocopherol and almost as effective as butylated hydroxytoluene (BHT). Various animal and human studies have shown that CLA can modulate both innate and adaptive immunity.

Anti-Obesity Effect of n-3 Polyunsaturated Fatty Acids in Mice Fed High-Fat Diet Is Independent of Cold-Induced Thermogenesis

Long-chain n-3 polyunsaturated fatty acids (LC n-3 PUFA) exert beneficial effects on health and they could help to prevent development of obesity and associated metabolic disorders. In our previous studies in mice fed high-fat (cHF; ~60 % calories as fat) diet and maintained at 20 °C, dietary LC n-3 PUFA could counteract accretion of body fat, without inducing mitochondrial uncoupling protein 1 (UCP1) in adipose tissue, suggesting that the anti-obesity effect was not linked to adaptive (UCP1-mediated) thermogenesis. To exclude a possible dependence of the anti-obesity effect on any mechanism inducible by cold, experiments were repeated in mice maintained at thermoneutrality (30 °C). Male C57BL/6J mice were fed either cHF diet, or cHF diet supplemented with LC n-3 PUFA, or standard diet for 7 months. Similarly as at 20 °C, the LC n-3 PUFA supplementation reduced accumulation of body fat, preserved lipid and glucose homeostasis, and induced fatty acid re-esterification in epididymal white adipose tissue. Food consumption was not affected by LC n-3 PUFA intake. Our results demonstrated anti-obesity metabolic effect of LC n-3 PUFA, independent of cold-induced thermogenesis and they suggested that induction of fatty acid re-esterification creating a substrate cycle in white fat, which results in energy expenditure, could contribute to the anti-obesity effect.

1400 Body Fat in VLBW is Influenced by Duration of Total Parenteral Nutrition (TPN)

BackgroundAdequate postnatal nutrition and growth are essential for optimal neurodevelopment in VLBW infants. In an effort to optimize nutrition, early TPN implementation is recommended while enteral nutrition is achieved. However,...

Effect of conjugated linoleic acid supplementation on body composition, body fat mobilization, protein accretion, and energy utilization in early lactation dairy cows

The objective of the study was to investigate the effects of trans-10,cis-12 and cis-9,trans-11 conjugated linoleic acid (CLA) supplementation on body composition, mobilization or accretion of body fat and protein mass, as well as the energy metabolism of dairy cows during the first 105 d in milk (DIM). For this purpose, a comparative slaughter experiment was conducted with 25 primiparous German Holstein cows. The experiment started at 1 DIM with the slaughter of 5 animals of an initial group receiving no CLA supplement. The remaining animals were fed a CLA supplement (n=10) or a stearic acid-based control fat supplement (CON; n=10) from 1 DIM up to slaughter. After 42 DIM, 5 more cows from each treatment (42-CLA and 42-CON) were slaughtered. The remaining 5 cows in each treatment were slaughtered after 105 DIM (105-CLA and 105-CON). The animals of the CLA groups consumed 6.0g/d of trans-10,cis-12 CLA and 5.7g/d of cis-9,trans-11 CLA. During the slaughter process, the empty body mass was recorded and partitioned into 9 fractions (meat, bone, offal, hide, mammary gland, retroperitoneal fat, omental fat, mesenteric fat, and s.c. fat). The fractions were analyzed for dry matter, ether extract, crude protein, and ash to calculate the body composition of the empty body mass at the different slaughter times. The principle of the comparative slaughter technique was applied to estimate body fat or protein mobilization and accretion in the viewed periods from 1 DIM until 42 and 105 DIM. The heat production (HP) was calculated by subtracting the energy in milk and energy changes in body mass from the metabolizable energy intake. The body composition was not affected by CLA supplementation. However, the mobilization of body fat mass from 1 until 42 DIM was 24.1kg in the 42-CON group and 14.3kg in the 42-CLA group. This resulted in a trend to lower body mass (fat and protein) mobilization of 10.5kg in the 42-CLA group. Energy mobilization from body mass was 21.2 MJ/d in the 42-CON and 11.5 MJ/d in the 42-CLA group. The HP was unchanged for the 42-CON and 42-CLA group with 123.0 and 116.9 MJ/d, respectively. From 1 until 105 DIM, the protein accretion was 4.3kg and the daily energy retention in body protein was 1.0 MJ higher for CLA-supplemented cows. The HP was decreased in this period for the 105-CLA group (115.5 MJ/d) as compared with the 105-CON group (125.9 MJ/d). Overall, the trend for a decreased body mass mobilization suggested a protective effect of CLA supplementation against excessive use of body reserves within 42 DIM. Continuous CLA supplementation until 105 DIM increased protein accretion. The effects on body mass mobilization and protein accretion in combination with the decreased HP in the CLA-fed cows suggested a more efficient utilization of metabolizable energy in CLA-supplemented early lactation dairy cows.

Lipid transport function is the main target of oral oleoylethanolamide to reduce adiposity in high-fat-fed mice

We evaluated the biological basis of reduced fat gain by oleoylethanolamide (OEA) in high-fat-fed mice and sought to determine how degradation of OEA affected its efficiency by comparing its effects to those of KDS-5104, a nonhydrolyzable lipid OEA analog. Mice were given OEA or KDS-5104 by the oral route (100 mg/kg body weight). Sixty-eight variables per mouse, describing six biological processes (lipid transport, lipogenesis, energy intake, energy expenditure, endocannabinoid signaling, and glucose metabolism), spanning gene expression of biochemical and physiological parameters were examined to determine the primary target whereby OEA reduces fat gain. Although KDS-5104 but not OEA was resistant to fatty acid amide hydrolase hydrolysis, OEA was degraded by an unidentified hydrolysis system in the liver. Nevertheless, both compounds equally decreased body fat pads after 5 weeks (20%; P < 0.05). The six biological functions constructed from the 68 initial variables predicted up to 58% of adipose fat variations. Lipid transport appeared central to the explanation for body fat deposition (16%; P < 0.0001), in which decreased expression of the FAT/CD36 gene was the component most related to adipose depots. Lipid transport appears to be a determinant player in the OEA fat-lowering response, with adipose tissue FAT/CD36 expression being the most relevant bioindicator of OEA action.

Effect of conjugated linoleic acid on body fat accretion in overweight or obese children

Conjugated linoleic acid (CLA) is a supplemental dietary fatty acid that decreases fat mass accretion in young animals. The aim of this study was to determine CLA's efficacy with regard to change in fat and body mass index (BMI; in kg/m(2)) in children. We conducted a 7 +/- 0.5-mo randomized, double-blind, placebo-controlled trial of CLA in 62 prepubertal children aged 6-10 y who were overweight or obese but otherwise healthy. The subjects were randomly assigned to receive 3 g/d of 80% CLA (50:50 cis-9,trans-11 and trans-10,cis-12 isomers) or placebo in chocolate milk. Fifty-three subjects completed the trial (n = 28 in the CLA group, n = 25 in the placebo group). CLA attenuated the increase in BMI (0.5 +/- 0.8) compared with placebo (1.1 +/- 1.1) (P = 0.05). The percentage change in body fat measured by dual-energy X-ray absorptiometry was smaller (P = 0.001) in the CLA group (-0.5 +/- 2.1%) than in the placebo group (1.3 +/- 1.8%). The change in abdominal body fat as a percentage of total body weight was smaller (P = 0.02) in the CLA group (-0.09 +/- 0.9%) than in the placebo group (0.43 +/- 0.6%). There were no significant changes in plasma glucose, insulin, or LDL cholesterol between groups. Plasma HDL cholesterol decreased significantly more (P = 0.05) in the CLA group (-5.1 +/- 7.3 mg/dL) than in the placebo group (-0.7 +/- 8 mg/dL). Bone mineral accretion was lower (P = 0.04) in the CLA group (0.05 +/- 0.03 kg) than in the placebo group (0.07 +/- 0.03 kg). Reported gastrointestinal symptoms did not differ significantly between groups. CLA supplementation for 7 +/- 0.5 mo decreased body fatness in 6-10-y-old children who were overweight or obese but did not improve plasma lipids or glucose and decreased HDL more than in the placebo group. Long-term investigation of the safety and efficacy of CLA supplementation in children is recommended.

Chronic suppression of μ-opioid receptor signaling in the nucleus accumbens attenuates development of diet-induced obesity in rats

ObjectiveTo test the hypothesis that mu-opioid receptor signaling in the nucleus accumbens contributes to hedonic (over)eating and obesity. To investigate the effects of chronic mu-opioid antagonism in the nucleus accumbens core or shell on intake of a palatable diet, and the development of diet-induced obesity in rats.Methods and DesignChronic blockade of mu-opioid receptor-signaling in the nucleus accumbens core or shell was achieved by means of repeated injections (every 4–5 days) of the irreversible receptor antagonist β-Funaltrexamine (BFNA) over 3–5 weeks. The diet consisted of either a choice of high-fat chow, chocolate-flavored Ensure, and regular chow (each nutritionally complete), or regular chow only. Intake of each food item, body weight, and body fat mass were monitored throughout the study.ResultsBFNA injections aimed at either the core or shell of the nucleus accumbens resulted in significantly attenuated intake of palatable diet, body weight gain, and fat accretion, compared with vehicle control injections. BFNA in the core did not significantly change these parameters in chow-fed control rats. BFNA in the core and shell differentially affected intake of the two palatable food items: in the core BFNA significantly reduced intake of high-fat, but not of Ensure, whereas in the shell, it significantly reduced intake of Ensure, but not of high-fat, compared with vehicle-treatment.ConclusionsEndogenous mu-opioid receptor-signaling in the nucleus accumbens core and shell is necessary for palatable diet-induced hyperphagia and obesity to fully develop in rats. Sweet and non-sweet fatty foods may be differentially processed in subcomponents of the ventral striatum.

Effects of supplemental exogenous emulsifier on performance, nutrient metabolism, and serum lipid profile in broiler chickens.

The effects of an exogenous emulsifier, glyceryl polyethylene glycol ricinoleate, on performance and carcass traits of broiler chickens were assessed. The emulsifier was added to the diet at dose rates of 0 (control), 1 (E1) and 2 (E2) % of added fat (saturated palm oil). Live weight gain (P < .07) and feed conversion ratio (P < .05) in 39 days were higher in the E1 dietary group. Gain: ME intake and gain: protein intake during the grower phase improved quadratically (P < .05). Gross carcass traits were not affected. Body fat content and fat accretion increased (P < .05) and liver fat content decreased (P < .05) linearly with the level of emulsifier in diet. Fat excretion decreased (P < .001) leading to increased ileal fat digestibility (P < .06) in the E1 group (quadratic response). Metabolizable intake of N (P < .1) and fat (P < .05) increased quadratically due to supplementation of emulsifier in diet. Metabolism of trace elements and serum lipid profiles were not affected. The study revealed that supplementation of exogenous emulsifiers in diets containing moderate quantities of added vegetable fats may substantially improve broiler performance.

Effects of Dietary Chromium (III) Picolinate on Growth Performance, Respiratory Rate, Plasma Variables, and Carcass Traits of Pigs Fed High-Fat Diets

We investigated the effects of supplemental chromium (Cr) as Cr (III) picolinate on pigs fed high-fat diets (HFD) in a 56-day experiment. Thirty-two crossbred pigs (9.6 kg) were allotted to four treatments with four blocks and two pigs/pen. Treatments included: (1) low-fat diet (fat < 3.5%; LFD) with no Cr, (2) HFD (fat > 30%) with no Cr, (3) HFD with 1,000 ppb Cr, and (4) HFD with 2,000 ppb Cr. Pigs fed HFD gained weight faster, consumed less, and had lower feed:gain (p < 0.05). Pigs fed HFD had higher respiration rates than pigs fed LFD on d 41 (p < 0.05). Plasma insulin on d 14 linearly decreased with Cr (p = 0.05). Plasma cholesterol concentrations were higher in the pigs fed HFD than those fed LFD, but were largely unaffected by supplemental Cr. Consumption of HFD resulted in greater carcass weight, perirenal fat, and backfat measures (p < 0.01) compared with the LFD group. Cr resulted in linear reductions of hot carcass weight (p = 0.08) and average backfat (p < 0.05). The effects of Cr on carcass fat measures were more pronounced in castrated males than in females. These results indicate that Cr attenuates some effects of a HFD, mainly body fat accretion of pigs, and especially in castrated pigs.

Deficiency of the intestinal enzyme acyl CoA:monoacylglycerol acyltransferase-2 protects mice from metabolic disorders induced by high-fat feeding

Animals are remarkably efficient in absorbing dietary fat and assimilating this energy-dense nutrient into the white adipose tissue (WAT) for storage. Although this metabolic efficiency may confer an advantage in times of calorie deprivation, it contributes to obesity and associated metabolic disorders when dietary fat is abundant. Here we show that the intestinal lipid synthesis enzyme acyl CoA:monoacylglycerol acyltransferase-2 (MGAT2) has a crucial role in the assimilation of dietary fat and the accretion of body fat in mice. Mice lacking MGAT2 have a normal phenotype on a low-fat diet. However, on a high-fat diet, MGAT2-deficient mice are protected against developing obesity, glucose intolerance, hypercholesterolemia and fatty livers. Caloric intake is normal in MGAT2-deficient mice, and dietary fat is absorbed fully. However, entry of dietary fat into the circulation occurs at a reduced rate. This altered kinetics of fat absorption apparently results in more partitioning of dietary fat toward energy dissipation rather than toward storage in the WAT. Thus, our studies identify MGAT2 as a key determinant of energy metabolism in response to dietary fat and suggest that the inhibition of this enzyme may prove to be a useful strategy for treating obesity and other metabolic diseases associated with excessive fat intake.

Poor Iron Status Is Not Associated with Overweight or Overfat in Non-Obese Pre-Menopausal Women

Background: Associations between obesity and poor iron status have been described in children and adults. Proposed mechanisms for this association implicate a physiologic etiology, suggesting body fat accretion may progressively degrade iron status. However, the relationship between iron status and body composition in non-obese adults remains unclear.Objective: In this study we examined the relationship between body composition, inflammation, and iron status in healthy, non-obese, pre-menopausal females.Methods: Iron status was assessed using red cell distribution width, transferrin saturation, serum ferritin, and soluble transferrin receptor (sTfR). Tumor-necrosis factor-α provided a marker of inflammation, and body fat percentage (BF) was calculated from mean skinfold thickness measurements at 3 sites.Results: In this cohort (n = 207), the prevalence of iron deficiency was similar (p > 0.05) between normal and overweight (BMI 25.0–30.0 kg/m2), and normal and overfat (BF ≥30.0%) volunteers. There were no differences in individual iron status indicators, including sTfR, between overweight or overfat volunteers as compared to normal weight and normal fat peers. Logistic regression analyses indicated that overfat volunteers had a lower (p < 0.05) risk of iron deficiency, whereas overweight individuals demonstrated no change in relative risk as compared to peers.Conclusion: These findings suggest that, in non-obese adults, decrements in iron status are not associated with increasing adiposity.

Effect of calcium-enriched high-fat diet on calcium, magnesium and zinc retention in mice

The aim of this work was to assess the effects of a high-fat diet enriched in Ca, which accompanies lower body fat deposition, on mineral depots, as well as to assess the potential role of adaptive thermogenesis in mice. Male mice were fed ad libitum a high-fat (43 %) diet with a Ca content of 4 g/kg from calcium carbonate (control group) or 12 g/kg (42 % from milk powder and the rest from calcium carbonate) (Ca group) for 56 d. Body weight, food intake and urine were periodically collected. Tissue samples were collected when the mice were killed and the composition was determined. Expression of uncoupling proteins was determined by Western blotting. Mineral content was measured by flame atomic absorption spectrometry. Lower body weight gain and fat accretion was found in the Ca group. This could not be attributable to lower gross energy intake or to activation of adaptive thermogenesis. Although significant urine mineral loss was found in the Ca group, preservation of mineral depots in bone was observed. Our data support the fact that adding more Ca to the diet, using a combination of calcium carbonate plus milk powder containing among other things higher Zn and Mg, contributes to counteracting obesity and improving lipid metabolism.

Dietary l-arginine supplementation increases muscle gain and reduces body fat mass in growing-finishing pigs

Obesity in humans is a major public health crisis worldwide. In addition, livestock species exhibit excessive subcutaneous fat at market weight. However, there are currently few means of reducing adiposity in mammals. This study was conducted with a swine model to test the hypothesis that dietary L-arginine supplementation may increase muscle gain and decrease fat deposition. Twenty-four 110-day-old barrows were assigned randomly into two treatments, representing supplementation with 1.0% L-arginine or 2.05% L-alanine (isonitrogenous control) to a corn- and soybean meal-based diet. Growth performance was measured based on weight gain and food intake. After a 60-day period of supplementation, carcass and muscle composition were measured. Serum triglyceride concentration was 20% lower (P < 0.01) but glucagon level was 36% greater (P < 0.05) in arginine-supplemented than in control pigs. Compared with the control, arginine supplementation increased (P < 0.05) body weight gain by 6.5% and carcass skeletal-muscle content by 5.5%, while decreasing (P < 0.01) carcass fat content by 11%. The arginine treatment enhanced (P < 0.05) longissimus dorsi muscle protein, glycogen, and fat contents by 4.8, 42, and 70%, respectively, as well as muscle pH at 45 min post-mortem by 0.32, while reducing muscle lactate content by 37%. These results support our hypothesis that dietary arginine supplementation beneficially promotes muscle gain and reduces body fat accretion in growing-finishing pigs. The findings have a positive impact on development of novel therapeutics to treat human obesity and enhance swine lean-tissue growth.

Physical Activity Prevents Augmented Body Fat Accretion in Moderately Iron-Deficient Rats

Recent studies describe an association between poor iron status and obesity in humans, although the mechanism explaining this relationship is unclear. The present study aimed to determine the effect of moderate iron deficiency and physical activity (PA) on body composition in an animal model. Male Sprague-Dawley rats consumed iron-adequate (IA; 40 mg/kg) or moderately iron-deficient (ID; 9 mg/kg) diets ad libitum for 12 wk. Rats were assigned to 4 treatment groups (n = 10 per group): IA, sedentary (IAS); IA, PA (IAPA); ID, sedentary (IDS); or ID, PA (IDPA). Activity involved running on motorized running wheels at 4 m/min for 1 h/d for 5 d/wk. After 12 wk, ID rats were not anemic, but body iron stores were reduced as indicated by diminished (P < 0.05) femur iron compared with IA rats. Treatment group did not affect body weight or feed consumption. However, fat mass was greater (P < 0.05) in IDS rats (38.6 ± 6.7%) than IAS (31.8 ± 2.9%), IAPA (31.8 ± 2.0%), and IDPA (32.8 ± 4.5%) rats. Furthermore, lean body mass was diminished in IDS rats (58.7 ± 6.8%) compared with IAS (65.6 ± 3.0%), IAPA (65.6 ± 2.1%), and IDPA (64.7 ± 4.5%) rats. Thus, moderate iron deficiency may cause increased body fat accretion in rats and PA attenuates that effect.